| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Eulàlia Montell | |
| Josep Vergés | |||
| Antonio G García | |||
| Patrick du Souich | |||
| P2860 | cites work | Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study | Q22000858 |
| Divergent roles for tumor necrosis factor-alpha in the brain | Q23916360 | ||
| Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease | Q24242101 | ||
| Acid mucopolysaccharides and lipids of Japanese arteries, with special reference to the absence of hyaluronic acid in Japanese cerebral artery | Q44394346 | ||
| Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial | Q44463935 | ||
| A disaccharide derived from chondroitin sulphate proteoglycan promotes central nervous system repair in rats and mice | Q45079445 | ||
| Chondroitin sulfate disaccharide stimulates microglia to adopt a novel regulatory phenotype. | Q45864337 | ||
| NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes | Q45889425 | ||
| Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses | Q46336822 | ||
| NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. | Q46345563 | ||
| Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation | Q46401891 | ||
| Glucosamine, a naturally occurring amino monosaccharide, suppresses dextran sulfate sodium-induced colitis in rats | Q46432918 | ||
| Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1beta-stimulated chondrocytes--study in hypoxic alginate bead cultures | Q80600333 | ||
| Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris | Q80845113 | ||
| Human mast cells stimulate activated T cells: implications for multiple sclerosis | Q82934524 | ||
| NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo | Q24679444 | ||
| Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation | Q24683293 | ||
| The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease | Q28207482 | ||
| Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease | Q28218124 | ||
| Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation | Q28757375 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Evolving concepts of rheumatoid arthritis | Q29618020 | ||
| Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial | Q30440147 | ||
| Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo | Q33199633 | ||
| Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view | Q33539765 | ||
| The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models | Q33894450 | ||
| Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study | Q33934367 | ||
| Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | Q33993736 | ||
| Chondroitin sulfate intake inhibits the IgE-mediated allergic response by down-regulating Th2 responses in mice | Q34074846 | ||
| Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? | Q34285595 | ||
| Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system | Q34335964 | ||
| Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches. | Q34395948 | ||
| Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease | Q34489699 | ||
| Mutations in the NF-kappaB signaling pathway: implications for human disease | Q34577553 | ||
| Curcumin: from ancient medicine to current clinical trials. | Q34589151 | ||
| Involvement of NF-kappaB signalling in skin physiology and disease. | Q34980890 | ||
| The extracellular matrix in axon regeneration | Q35002818 | ||
| The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease | Q35172428 | ||
| Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders | Q35183966 | ||
| Activation of nuclear factor kappa B inflammatory bowel disease | Q35350256 | ||
| Chondroitin sulphation patterns in synovial fluid in osteoarthritis subsets | Q35548692 | ||
| Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis | Q35609103 | ||
| An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes | Q35768672 | ||
| Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology. | Q35788090 | ||
| The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment | Q35793760 | ||
| Antipsoriatic effects of avarol-3'-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin | Q36094366 | ||
| Lessons from genetic forms of osteoarthritis for the pathogenesis of the disease | Q36113988 | ||
| Cellular and molecular immunopathogenesis of ulcerative colitis | Q36426112 | ||
| Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages | Q46523553 | ||
| Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. | Q46545785 | ||
| Effects of proteoglycan on dextran sulfate sodium-induced experimental colitis in rats | Q46606681 | ||
| Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats | Q46649649 | ||
| FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. | Q46718326 | ||
| Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response | Q46815008 | ||
| Attenuation of experimental colonic injury by thiazolidinedione agents | Q46835770 | ||
| Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants | Q46840579 | ||
| A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration | Q46882495 | ||
| Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes | Q46914099 | ||
| Molecular chaperone alpha-crystallin prevents detrimental effects of neuroinflammation | Q46916713 | ||
| Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. | Q46946754 | ||
| Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination | Q46968199 | ||
| A selective small molecule IkappaB Kinase beta inhibitor blocks nuclear factor kappaB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells | Q46981372 | ||
| A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease | Q48379797 | ||
| Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions | Q48463773 | ||
| Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study | Q48592216 | ||
| Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. | Q48853057 | ||
| Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs | Q49044428 | ||
| Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 | ||
| Effects of chondroitin sulfate-C on articular cartilage destruction in murine collagen-induced arthritis. | Q51411662 | ||
| Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding. | Q53867225 | ||
| [Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases]. | Q53878167 | ||
| [6-hydroxy-1,3-benzoxathiol-2-one, an antipsoriatic with antibacterial and antimycotic properties] | Q53912049 | ||
| Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin | Q57244267 | ||
| Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease | Q57569294 | ||
| Infra-red Spectroscopic Evidence of Chondroitin Polysulphate and its Relation to Anticoagulant Activity | Q58999918 | ||
| The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis | Q59087662 | ||
| Chondroitin Sulfate-Derived Disaccharide Protects Retinal Cells from Elevated Intraocular Pressure in Aged and Immunocompromised Rats | Q60189228 | ||
| Reduction of proinflammatory cytokine expression in the synovium by targeting IKKbeta in vivo in a rat model | Q64377429 | ||
| Response of ischemic heart disease to chondroitin sulfate-A | Q70120083 | ||
| Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated prot | Q73165868 | ||
| Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3 | Q73678522 | ||
| IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages | Q74412124 | ||
| Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? | Q74561877 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q77320493 | ||
| Inhibition of articular cartilage degradation by glucosamine-HCl and chondroitin sulphate | Q78444082 | ||
| Effect of chondroitin sulfate on murine splenocytes sensitized with ovalbumin | Q78467470 | ||
| The Effects of Sulfated Polysaccharides Obtained From Seaweeds on Experimental Atherosclerosis | Q79028605 | ||
| Interleukin-1beta induced activation of nuclear factor-kappab can be inhibited by novel pharmacological agents in osteoarthritis | Q79544931 | ||
| Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes | Q79807781 | ||
| Inhibition of interleukin-1beta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1: potential mechanism for Diacerein effects in osteoarthritis | Q80123204 | ||
| Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis | Q37307893 | ||
| The bright side of the glial scar in CNS repair | Q37396812 | ||
| Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice | Q39573247 | ||
| Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats | Q39677660 | ||
| Mixed extracellular matrix ligands synergistically modulate integrin adhesion and signaling | Q39963439 | ||
| The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells | Q39970700 | ||
| Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase/Akt | Q40077832 | ||
| Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways | Q40123747 | ||
| Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes | Q40332650 | ||
| Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation | Q40437395 | ||
| Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation | Q41994314 | ||
| Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept | Q42479845 | ||
| Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study | Q42521491 | ||
| Role of Toll-like receptors in health and diseases of gastrointestinal tract | Q42726049 | ||
| Molecular mechanisms of cartilage destruction: mechanics, inflammatory mediators, and aging collide | Q43004023 | ||
| Synovial tissue inflammation in early and late osteoarthritis | Q43048512 | ||
| Effects of chondroitin sulfate on colitis induced by dextran sulfate sodium in rats | Q43564520 | ||
| Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes | Q43992050 | ||
| Chondroitin sulfate in erosive osteoarthritis of the hands | Q43995164 | ||
| Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes | Q44159758 | ||
| Oral bioavailability of chondroitin sulfate (Condrosulf) and its constituents in healthy male volunteers | Q44163866 | ||
| Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the alpha5 integrin receptor subunit | Q44237624 | ||
| Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis | Q44247093 | ||
| Concomitant recruitment of ERK1/2 and p38 MAPK signalling pathway is required for activation of cytoplasmic phospholipase A2 via ATP in articular chondrocytes | Q44319464 | ||
| Coronary heart disease: reduction of death rate by chondroitin sulfate A. | Q44382865 | ||
| Osteoarthritis: pathobiology-targets and ways for therapeutic intervention | Q36449936 | ||
| The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? | Q36470227 | ||
| NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis | Q36490904 | ||
| Osteoarthritis and therapy. | Q36494303 | ||
| The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development | Q36592804 | ||
| Contemporary concepts of inflammation, damage and repair in rheumatic diseases. | Q36596126 | ||
| Update on the biology of the chondrocyte and new approaches to treating cartilage diseases | Q36596176 | ||
| NF-kappaB functions in the nervous system: from development to disease | Q36602096 | ||
| NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach | Q36631434 | ||
| Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification. | Q36684209 | ||
| Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis | Q36736328 | ||
| Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis | Q36737786 | ||
| Mucopolysaccharides in synovial fluid detection of chondroitin sulphate | Q36756064 | ||
| Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. | Q36818461 | ||
| Analytical aspects of pharmaceutical grade chondroitin sulfates. | Q36881374 | ||
| Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues. | Q36888475 | ||
| Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? | Q36902290 | ||
| Neuroinflammation and its modulation by flavonoids | Q36952410 | ||
| The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis | Q36955377 | ||
| Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks | Q37028416 | ||
| Role of TNF-alpha in vascular dysfunction | Q37050343 | ||
| Molecular mechanism of PPAR in the regulation of age-related inflammation | Q37099509 | ||
| Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals | Q37108848 | ||
| A review of infliximab use in ulcerative colitis. | Q37110988 | ||
| PPAR: a therapeutic target in Parkinson's disease. | Q37126858 | ||
| Cartilage in normal and osteoarthritis conditions | Q37154103 | ||
| Extracellular matrix and pathogenic mechanisms in osteoarthritis | Q37154859 | ||
| NF-kappaB in inflammatory bowel disease | Q37163422 | ||
| Cardiac role of the transcription factor NF-kappaB. | Q37184904 | ||
| Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker | Q37206536 | ||
| Anti-inflammatory activity of chondroitin sulfate | Q37230656 | ||
| PPAR Regulation of Inflammatory Signaling in CNS Diseases | Q37231755 | ||
| Interplay between effector Th17 and regulatory T cells | Q37276852 | ||
| P433 | issue | 8A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| carbohydrate | Q11358 | ||
| anti-inflammatory agent | Q581996 | ||
| immunologic factor | Q50349184 | ||
| P304 | page(s) | 1451-1463 | |
| P577 | publication date | 2009-06-11 | |
| 2009-08-01 | |||
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate | |
| P478 | volume | 13 |
| Q41820473 | A Dual-Bonded Approach for Improving Hydrogel Implant Stability in Cartilage Defects |
| Q91565305 | A comparative analysis of secreted protein disulfide isomerases from the tropical co-endemic parasites Schistosoma mansoni and Leishmania major |
| Q89229355 | Anti-Inflammatory Effect of Carprofen Is Enhanced by Avocado/Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination in Chondrocyte Microcarrier Spinner Culture |
| Q26862600 | Anti-inflammatory strategies in cartilage repair |
| Q47992126 | Anti-oxidant and immune-modulatory properties of sulfated alginate derivatives on human chondrocytes and macrophages |
| Q39245371 | Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model |
| Q30426452 | Biomedical Applications of Biodegradable Polymers |
| Q30826826 | Biotechnological Chondroitin a Novel Glycosamminoglycan With Remarkable Biological Function on Human Primary Chondrocytes. |
| Q57788682 | CHSY1 promoted proliferation and suppressed apoptosis in colorectal cancer through regulation of the NFκB and/or caspase-3/7 signaling pathway |
| Q41014505 | Chondroitin Lyase from a Marine Arthrobacter sp. MAT3885 for the Production of Chondroitin Sulfate Disaccharides. |
| Q36808577 | Chondroitin Sulfate Immobilized on a Biomimetic Scaffold Modulates Inflammation While Driving Chondrogenesis. |
| Q64253125 | Chondroitin Sulfate Safety and Quality |
| Q64935652 | Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response. |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q37391095 | Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study |
| Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
| Q40790185 | Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation |
| Q91372005 | Chondroitin sulfate-polydopamine modified polyethylene terephthalate with extracellular matrix-mimetic immunoregulatory functions for osseointegration |
| Q34906145 | Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI |
| Q49393288 | Comparison of the effects of exercise with chondroitin sulfate on knee osteoarthritis in rabbits |
| Q34189460 | Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology |
| Q93016657 | Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q39510798 | Effects of chondroitin sulfate and its oligosaccharides on toll-like receptor-mediated IL-6 secretion by macrophage-like J774.1 cells |
| Q57423741 | Enzymatically Sensitive Fiber-Forming Bioresorbable Polymers |
| Q92372433 | Galactosaminoglycans: Medical Applications and Drawbacks |
| Q38669607 | Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study |
| Q35078145 | Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases |
| Q34303993 | Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis? |
| Q36661257 | Novel polypyrrole-coated polylactide scaffolds enhance adipose stem cell proliferation and early osteogenic differentiation |
| Q35953414 | Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial |
| Q93135737 | Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis |
| Q47961461 | Quantification and comparison of acidic polysaccharides in edible fish intestines and livers using HPLC-MS/MS. |
| Q37696562 | Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation. |
| Q90479612 | Regulation of Macrophage and Dendritic Cell Function by Chondroitin Sulfate in Innate to Antigen-Specific Adaptive Immunity |
| Q51088616 | Sulfated hyaluronan attenuates inflammatory signaling pathways in macrophages involving induction of antioxidants. |
| Q89861496 | The Role of Glycosaminoglycans in Protection from Neonatal Necrotizing Enterocolitis: A Narrative Review |
| Q40971693 | The extracellular matrix of eggshell displays anti-inflammatory activities through NF-κB in LPS-triggered human immune cells |
| Q98771940 | Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease |
| Q36535288 | Treatment with chondroitin sulfate to modulate inflammation and atherogenesis in obesity |
| Q89340157 | α-Lipoic Acid Potentiates the Anti-Inflammatory Activity of Avocado/Soybean Unsaponifiables in Chondrocyte Cultures |
| Q48164902 | α-Spinasterol: a COX inhibitor and a transient receptor potential vanilloid 1 antagonist presents an antinociceptive effect in clinically relevant models of pain in mice. |
Search more.